<DOC>
	<DOC>NCT01324362</DOC>
	<brief_summary>The purpose of this study was to determine whether asthma control and reduced bronchial responsiveness could be achieved and maintained at a lower dose of inhaled corticosteroids with ADVAIR DISKUS BID or FP BID in adult and adolescent patients with persistent asthma</brief_summary>
	<brief_title>GSK BHR Study (Sont - Second Study)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Diagnosis of asthma Controller asthma medication or medium dose ICS Current or historical reversibility Lifethreatening asthma Asthma instability Concurrent respiratory disease Drug allergies Respiratory tract infection Systemic corticosteroid use Immunosuppressive medication use Postive pregnancy test Tobacco use Investigation medication use Site affiliation</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>FP</keyword>
	<keyword>Asthma</keyword>
	<keyword>Sont</keyword>
	<keyword>FSC</keyword>
	<keyword>BHR</keyword>
</DOC>